608 related articles for article (PubMed ID: 16818868)
41. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.
Pouwels PJ; Brockmann K; Kruse B; Wilken B; Wick M; Hanefeld F; Frahm J
Pediatr Res; 1999 Oct; 46(4):474-85. PubMed ID: 10509371
[TBL] [Abstract][Full Text] [Related]
42. Metabolite alterations in autistic children: a 1H MR spectroscopy study.
Kubas B; Kułak W; Sobaniec W; Tarasow E; Lebkowska U; Walecki J
Adv Med Sci; 2012 Jun; 57(1):152-6. PubMed ID: 22472469
[TBL] [Abstract][Full Text] [Related]
43. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
[TBL] [Abstract][Full Text] [Related]
44. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
45. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
46. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy.
Fayed N; Modrego PJ
Acad Radiol; 2005 May; 12(5):566-9. PubMed ID: 15866128
[TBL] [Abstract][Full Text] [Related]
47. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study.
DeVito TJ; Drost DJ; Neufeld RW; Rajakumar N; Pavlosky W; Williamson P; Nicolson R
Biol Psychiatry; 2007 Feb; 61(4):465-73. PubMed ID: 17276747
[TBL] [Abstract][Full Text] [Related]
48. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
49. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
50. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
51. A proton spectroscopy study of white matter in children with autism.
Hardan AY; Fung LK; Frazier T; Berquist SW; Minshew NJ; Keshavan MS; Stanley JA
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():48-53. PubMed ID: 26593330
[TBL] [Abstract][Full Text] [Related]
52. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.
Pfefferbaum A; Adalsteinsson E; Spielman D; Sullivan EV; Lim KO
Arch Gen Psychiatry; 1999 Feb; 56(2):185-92. PubMed ID: 10025444
[TBL] [Abstract][Full Text] [Related]
53. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.
Coplan JD; Mathew SJ; Mao X; Smith EL; Hof PR; Coplan PM; Rosenblum LA; Gorman JM; Shungu DC
Psychiatry Res; 2006 Jun; 147(1):27-39. PubMed ID: 16797939
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
55. Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy.
Lundbom N; Gaily E; Vuori K; Paetau R; Liukkonen E; Rajapakse JC; Valanne L; Häkkinen AM; Granström ML
Epilepsia; 2001 Dec; 42(12):1507-14. PubMed ID: 11879360
[TBL] [Abstract][Full Text] [Related]
56. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
57. In vivo quantitative proton MRSI study of brain development from childhood to adolescence.
Horská A; Kaufmann WE; Brant LJ; Naidu S; Harris JC; Barker PB
J Magn Reson Imaging; 2002 Feb; 15(2):137-43. PubMed ID: 11836768
[TBL] [Abstract][Full Text] [Related]
58. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
59. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
60. Trace apparent diffusion coefficients of metabolites in human brain using diffusion weighted magnetic resonance spectroscopy.
Ellegood J; Hanstock CC; Beaulieu C
Magn Reson Med; 2005 May; 53(5):1025-32. PubMed ID: 15844150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
